Agenda for Day 1 - Monday 9 November, 2026
Location: Business of Biotech Stage
Early-stage investment is the lifeblood of biotech innovation, powering groundbreaking ideas and transformative discoveries. This panel brings together seasoned investors, industry leaders, and ambitious entrepreneurs to explore the current state of early-stage funding in biotech. From emerging investment strategies to the evolving priorities of venture capital, gain a deeper understanding of how startups are securing the resources they need to thrive. Hear firsthand accounts of challenges, opportunities, and the critical factors shaping the future of biotech funding. Whether you’re building, investing, or simply curious, this session offers a front-row seat to the forces driving biotech’s next wave of growth.
- Orsolya Symmons - Programme Manager for Health & Biotechnology, European Innovation Council
- Lovisa Backemar - Partner, Eir Ventures
- Juri Bach - Senior Investment Manager, HTGF
- Rabab Nasrallah - Partner, Earlybird Venture Capital
- Karl Naegler - Partner, Sofinnova Partners
- Bonnie van Wilgenburg - Venture Partner, Bioqube Ventures
